RIBOPRO BV


RIBOPRO is dedicated to revolutionizing medicine through innovative mRNA technologies. They aim to be the premier partner in mRNA development, providing high-quality materials, advanced manufacturing processes, and a broad range of services to accelerate the development of life-science products. Their mission is to support RNA-therapy pioneers in creating better medicines and addressing societal challenges, with a vision that by 2043, 90% of new medicines will be RNA-based, contributing to cures for chronic illnesses and affordability of treatments.

Industries

biotechnology
clinical-trials
health-diagnostics

Nr. of Employees

small (1-50)

RIBOPRO BV

Oss, Noord-Brabant, The Netherlands, Europe


Products

mRNA Manufacturing

Production of high-quality mRNA using proprietary methods, ensuring high purity, complete capping, and well-defined poly(A)-tails.

LNP Formulation

Encapsulation of mRNA into lipid nanoparticles (LNPs) with control over size, PDI, and zeta-potential.

Custom mRNA Synthesis

Creation of custom mRNA sequences for research and development, with options for sequence optimization and various capping and tailing choices.

Off-the-Shelf Reporter mRNA

Ready-to-use mRNA products like eGFP and FLuc mRNA, verified for performance and available for immediate use.

Contract Research Services

Standardized assays to assess the activity, toxicity, and immunogenicity of mRNA and LNP formulations.

Formulation Services

Formulation of purchased mRNA into various nanoparticle technologies, including cationic peptides, polymers, and lipids.


Services

mRNA manufacturing

High-quality, high-performance mRNA manufactured with the newest techniques, with a short turn-around time.

LNP formulation

High-efficiency encapsulation of mRNA into LNPs with control over size, PDI and zeta-potential.

Success services

Assistance in designing experiments, interpreting data, and advising on development to ensure success.

Real-world evidence

Providing evidence and case studies of their mRNA technologies in real applications.

Lipid-based transfection

Efficient delivery of nucleic acids into zebrafish embryos using lipid-based transfection with Lipofectamine LTX, offering a high-throughput, cost-effective alternative to microinjection.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.